127 related articles for article (PubMed ID: 38235544)
1. Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
Li J; Takeda M; Imahatakenaka M; Ikeda M
J Med Virol; 2024 Jan; 96(1):e29372. PubMed ID: 38235544
[TBL] [Abstract][Full Text] [Related]
2. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
Hickerson BT; Petrovskaya SN; Dickensheets H; Donnelly RP; Ince WL; Ilyushina NA
J Virol; 2023 Jul; 97(7):e0015423. PubMed ID: 37404185
[TBL] [Abstract][Full Text] [Related]
3. Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.
Yang Y; Gao Y; Zhang L; Liu X; Sun Y; Bai J; Jiang P
Vet Res; 2023 Dec; 54(1):124. PubMed ID: 38124181
[TBL] [Abstract][Full Text] [Related]
4. The Novel
Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
6. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
Smee DF; Hurst BL; Day CW
Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of galectin-3 in influenza A virus infection promotes viral RNA synthesis through its association with viral PA protein.
Yang ML; Chen YC; Wang CT; Chong HE; Chung NH; Leu CH; Liu FT; Lai MMC; Ling P; Wu CL; Shiau AL
J Biomed Sci; 2023 Feb; 30(1):14. PubMed ID: 36823664
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
9. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle.
Hegazy A; Soltane R; Alasiri A; Mostafa I; Metwaly AM; Eissa IH; Mahmoud SH; Allayeh AK; Shama NMA; Khalil AA; Barre RS; El-Shazly AM; Ali MA; Martinez-Sobrido L; Mostafa A
BMC Complement Med Ther; 2024 Jan; 24(1):49. PubMed ID: 38254071
[TBL] [Abstract][Full Text] [Related]
10. Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK/MAPK signaling, and blockade of influenza A virus vRNP nuclear export.
Yang X; Long F; Jia W; Zhang M; Su G; Liao M; Zeng Z; Chen W; Chen J
Antiviral Res; 2023 Jul; 215():105635. PubMed ID: 37192683
[TBL] [Abstract][Full Text] [Related]
11. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions.
Guo H; Liu D; Liu K; Hou Y; Li C; Li Q; Ding X; Verstegen MMA; Zhang J; Wang L; Ding Y; Tang R; Pan X; Zheng K; van der Laan LJW; Pan Q; Wang W
Virol Sin; 2024 Feb; 39(1):123-133. PubMed ID: 37984761
[TBL] [Abstract][Full Text] [Related]
13. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
[TBL] [Abstract][Full Text] [Related]
14. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Aryl Benzoyl Hydrazide Derivatives as Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (RdRp).
Liu X; Liang J; Yu Y; Han X; Yu L; Chen F; Xu Z; Chen Q; Jin M; Dong C; Zhou HB; Lan K; Wu S
J Med Chem; 2022 Mar; 65(5):3814-3832. PubMed ID: 35212527
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
[TBL] [Abstract][Full Text] [Related]
17. Identification of Amino Acid Residues Required for Inhibition of Host Gene Expression by Influenza Virus A/Viet Nam/1203/2004 H5N1 PA-X.
Chiem K; López-García D; Ortego J; Martinez-Sobrido L; DeDiego ML; Nogales A
J Virol; 2022 Mar; 96(5):e0040821. PubMed ID: 33853954
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment.
Yang X; Sun H; Zhang Z; Ou W; Xu F; Luo L; Liu Y; Chen W; Chen J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902398
[TBL] [Abstract][Full Text] [Related]
19. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.
Spieler EE; Moritz E; Stertz S; Hale BG
mSphere; 2020 Aug; 5(4):. PubMed ID: 32848003
[TBL] [Abstract][Full Text] [Related]
20. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
